Concepedia

Marjan Zaman

MZ

Statistics

Publications

6

Citations

498

H-Index

6

Active since

2016

Affiliations

Cornell University(Current)

Weill Cornell Medicine

Molecular Innovations (United States)

Marjan Zaman is an author at Cornell University specializing in oncology, chimeric antigen receptor t-cell therapy, and cancer immunotherapy.

Publications per year

2016–2020

6

Publications

6

Micromolar affinity CAR T cells to ICAM-1 achieves rapid tumor elimination while avoiding systemic toxicity

Spencer Park, Enda Shevlin, Yogindra Vedvyas et al. · Scientific Reports · 2017 · 167 citations · Full text

, , +17

CAR T Therapy Targeting ICAM-1 Eliminates Advanced Human Thyroid Tumors

Irene M. Min, Enda Shevlin, Yogindra Vedvyas et al. · Clinical Cancer Research · 2017 · 99 citations

, , +12

Longitudinal PET imaging demonstrates biphasic CAR T cell responses in survivors

Yogindra Vedvyas, Enda Shevlin, Marjan Zaman et al. · JCI Insight · 2016 · 90 citations · Full text

, , +17

Chimeric Antigen Receptor T Cell Therapy Targeting ICAM-1 in Gastric Cancer

Minkyu Jung, Yanping Yang, Jaclyn E. McCloskey et al. · Molecular Therapy — Oncolytics · 2020 · 62 citations · Full text

, , +17

PD1 Blockade Enhances ICAM1-Directed CAR T Therapeutic Efficacy in Advanced Thyroid Cancer

Katherine D. Gray, Jaclyn E. McCloskey, Yogindra Vedvyas et al. · Clinical Cancer Research · 2020 · 49 citations · Full text

, , +17

1–5 of 6